Barkin Jack, Giddens Jonathan, Incze Peter, Casey Richard, Richardson Stephen, Gange Steven
Humber River Regional Hospital, University of Toronto, Toronto, Ontario, Canada.
Can J Urol. 2012 Apr;19(2):6217-22.
Many men with benign prostatic hyperplasia (BPH) forego therapy because they are dissatisfied with current treatment options. While surgical resection and ablation using many different forms of energy remain the reference standard for BPH treatment, many men seek a less invasive technique that will improve symptoms but not risk the complications associated with tissue removal. The Prostatic Urethral Lift opens the prostatic urethra with UroLift (NeoTract Inc., Pleasanton, CA, USA) permanent implants that are delivered under cystoscopic visualization. The implants literally "hold open" the lateral prostatic lobes creating a passage through the obstructed prostatic urethra. Voiding and symptoms are significantly improved without the morbidity or possible complications following prostate resection. The entire procedure can be readily performed using local anesthesia. As with all new implant procedures, the technique has evolved with experience. The objective of this article is to describe the most current technique for the delivery of the UroLift implant in order to achieve maximal impact on symptom relief.
许多患有良性前列腺增生(BPH)的男性放弃治疗,因为他们对当前的治疗选择不满意。虽然使用多种不同能量形式的手术切除和消融仍然是BPH治疗的参考标准,但许多男性寻求一种侵入性较小的技术,这种技术既能改善症状,又不会有与组织切除相关的并发症风险。前列腺尿道悬吊术使用UroLift(美国加利福尼亚州普莱森顿的NeoTract公司)永久性植入物在膀胱镜直视下打开前列腺尿道。这些植入物实际上“撑开”前列腺侧叶,在受阻的前列腺尿道中形成一条通道。排尿和症状得到显著改善,且没有前列腺切除术后的发病率或可能的并发症。整个手术可以很容易地在局部麻醉下进行。与所有新的植入手术一样,该技术随着经验的积累而不断发展。本文的目的是描述UroLift植入物最当前的递送技术,以实现对症状缓解的最大影响。